agar io

The 'BiopSee' machine, funded through charitable donations 

Supporting innovative technologies and personalised treatments

Specialists in Cambridge have been developing cutting edge technologies in imaging, biopsy and genetic profiling in prostate and breast cancer, primarily in research and trial situations.

They now want to bring that knowledge into direct patient care by identifying tailored and personalised treatments with the most up-to-date technologies for breast cancer and prostate cancer patients to enable them to receive the best possible care.